Storz E, Gschwend J E, Retz M
Urologische Klinik und Poliklinik, Klinikum rechts der Isar, Technische Universität München, Ismaninger Str. 22, 81675, München, Deutschland.
Urologe A. 2018 May;57(5):532-542. doi: 10.1007/s00120-018-0606-6.
The chemotherapy-induced nausea and vomiting (CINV) is one of the most frequent side effects in cytostatic therapy and a profound challenge during the therapy of cancer patients. Therefore, standardized guideline-orientated prophylaxis is essential and a fundamental contribution for the success of treatment. This review summarizes the current recommendations for CINV of the Multinational Association of Supportive Care in Cancer (MASCC) and European Society of Medical Oncology (ESMO), the American Society for Clinical Oncology (ASCO), the National Comprehensive Cancer Network (NCCN) and the S3-guideline Supportive Therapie of the Leitlinienprogramm Onkologie and shall facilitate its use in the daily routine.
化疗引起的恶心和呕吐(CINV)是细胞毒性治疗中最常见的副作用之一,也是癌症患者治疗期间面临的巨大挑战。因此,标准化的、以指南为导向的预防措施至关重要,是治疗成功的根本保障。本综述总结了癌症多国支持治疗协会(MASCC)和欧洲医学肿瘤学会(ESMO)、美国临床肿瘤学会(ASCO)、美国国立综合癌症网络(NCCN)以及德国肿瘤学指南计划的S3指南支持治疗中关于CINV的当前建议,以促进其在日常临床中的应用。